32 results on '"Lombardo, Claudio"'
Search Results
2. Collaborating with cancer patients and informal caregivers in a European study on quality of life: protocol to embed patient and public involvement within the EUonQoL project.
- Author
-
Engelaar M, Bos N, van Schelven F, Lorenzo I Sunyer N, Couespel N, Apolone G, Brunelli C, Caraceni A, Ferrer M, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Gilbert A, and Rademakers J
- Abstract
Background: Patient and public involvement (PPI) has become an essential part of health research. There is a need for genuine involvement in order to ensure that research is relevant to patients. This can then improve the quality, relevance, and impact of health research, while at the same time reducing wasted research and in doing so bringing science and society closer together. Despite the increasing attention for this involvement, it is not yet common practice to report on proposed activities. An article reporting planned PPI could provide guidance and inspiration for the wider academic community in future activities. Therefore, this current article aims to describe the way in which PPI principles are incorporated in the research project called "Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe (EUonQoL)." This project aims to develop a new set of questionnaires to enable cancer patients to assess their quality of life, entitled the EUonQoL-Kit., Methods: The first step is to recruit cancer patients and their informal caregivers as co-researchers in order to train them to collaborate with the researchers. Based on their skills and preferences, they are then assigned to several of the project's work packages. Their individual roles, tasks, and responsibilities regarding the work packages, to which they have been assigned, are evaluated and adapted when necessary. The impact of their involvement is evaluated by both the researchers and co-researchers., Discussion: PPI is a complex and dynamic process. As such, the overall structure of the research may be defined while at the same time leaving room for certain aspects to be filled in later. Our research is, we believe, relevant as co-researcher involvement in such a large European project as EUonQoL is a new development., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
3. Psychosocial factors associated with quality of life in cancer survivors: umbrella review.
- Author
-
Voskanyan V, Marzorati C, Sala D, Grasso R, Pietrobon R, van der Heide I, Engelaar M, Bos N, Caraceni A, Couspel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Sirven A, Vachon H, Velikova G, Brunelli C, Apolone G, and Pravettoni G
- Subjects
- Humans, Quality of Life, Cancer Survivors psychology, Neoplasms psychology
- Published
- 2024
- Full Text
- View/download PDF
4. Use of information and communication technologies (ICTs) in cancer multidisciplinary team meetings: an explorative study based on EU healthcare professionals.
- Author
-
Prades J, Coll-Ortega C, Dal Lago L, Goffin K, Javor E, Lombardo C, de Munter J, Ponce J, Regge D, Salazar R, Valentini V, and Borras JM
- Subjects
- Communication, Delivery of Health Care, Humans, Patient Care Team, Information Technology, Neoplasms therapy
- Abstract
Objectives: Multidisciplinary teams in cancer care are increasingly using information and communication technology (ICT), hospital health information system (HIS) functionalities and ICT-driven care components. We aimed to explore the use of these tools in multidisciplinary team meetings (MTMs) and to identify the critical challenges posed by their adoption based on the perspective of professionals representatives from European scientific societies., Design: This qualitative study used discussion of cases and focus group technique to generate data. Thematic analysis was applied., Setting: Healthcare professionals working in a multidisciplinary cancer care environment., Participants: Selection of informants was carried out by European scientific societies in accordance with professionals' degree of experience in adopting the implementation of ICT and from different health systems., Results: Professionals representatives of 9 European scientific societies were involved. Up to 10 ICTs, HIS functionalities and care components are embedded in the informational and decision-making processes along three stages of MTMs. ICTs play a key role in opening MTMs to other institutions (eg, by means of molecular tumour boards) and information types (eg, patient-reported outcome measures), and in contributing to the internal efficiency of teams. While ICTs and care components have their own challenges, the information technology context is characterised by the massive generation of unstructured data, the lack of interoperability between systems from different hospitals and HIS that are conceived to store and classify information rather than to work with it., Conclusions: The emergence of an MTM model that is better integrated in the wider health system context and incorporates inputs from patients and support systems make traditional meetings more dynamic and interconnected. Although these changes signal a second transition in the development process of multidisciplinary teams, they occur in a context marked by clear gaps between the information and management needs of MTMs and the adequacy of current HIS., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
5. Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks.
- Author
-
Kehrloesser S, Oberst S, Westerhuis W, Wendler A, Wind A, Blaauwgeers H, Burrion JB, Nagy P, Saeter G, Gustafsson E, De Paoli P, Lovey J, Lombardo C, Philip T, de Valeriola D, Docter M, Boomsma F, Saghatchian M, Svoboda M, Philip I, Monetti F, Hummel H, McVie G, Otter R, and van Harten W
- Subjects
- Academies and Institutes standards, Academies and Institutes statistics & numerical data, Biomedical Research organization & administration, Biomedical Research standards, Biomedical Research statistics & numerical data, Cohort Studies, Europe epidemiology, Humans, Medical Oncology standards, Medical Oncology statistics & numerical data, Neoplasms epidemiology, Patient Care Team organization & administration, Patient Care Team standards, Patient Care Team statistics & numerical data, Patient-Centered Care organization & administration, Patient-Centered Care standards, Patient-Centered Care statistics & numerical data, Translational Research, Biomedical methods, Translational Research, Biomedical organization & administration, Translational Research, Biomedical statistics & numerical data, Cancer Care Facilities organization & administration, Cancer Care Facilities statistics & numerical data, Neoplasms therapy, Quality of Health Care
- Abstract
There is a persistent variation in cancer outcomes among and within European countries suggesting (among other causes) inequalities in access to or delivery of high-quality cancer care. European policy (EU Cancer Mission and Europe's Beating Cancer Plan) is currently moving towards a mission-oriented approach addressing these inequalities. In this study, we used the quantitative and qualitative data of the Organisation of European Cancer Institutes' Accreditation and Designation Programme, relating to 40 large European cancer centres, to describe their current compliance with quality standards, to identify the hallmarks common to all centres and to show the distinctive features of Comprehensive Cancer Centres. All Comprehensive Cancer Centres and Cancer Centres accredited by the Organisation of European Cancer Institutes show good compliance with quality standards related to care, multidisciplinarity and patient centredness. However, Comprehensive Cancer Centres on average showed significantly better scores on indicators related to the volume, quality and integration of translational research, such as high-impact publications, clinical trial activity (especially in phase I and phase IIa trials) and filing more patents as early indicators of innovation. However, irrespective of their size, centres show significant variability regarding effective governance when functioning as entities within larger hospitals., (© 2021 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.)
- Published
- 2021
- Full Text
- View/download PDF
6. What could be a cancer mission objective if we join our forces in the fight against cancer?
- Author
-
Philip T, Karjalainen S, De Lorenzo F, Apostolidis K, Lombardo C, Nilbert M, Lacombe D, Poortmans P, Albreht T, Kearns P, and Vassal G
- Abstract
The European cancer burden is growing rapidly, with an estimated 2 million deaths a year according to the latest research. As almost half of cancers are diagnosed after the age of 65, and considering the aging European population, a tidal wave of cancer cases will sweep across Europe within the coming decades. Without major action, the additional number of annual cancer cases is expected to rise from 4.2 million to 5.2 million by 2040. If we are to reach plateauing numbers by 2040 (as a minimum goal), this would require 0.75% annual reduction in risk and 1% reduction in risk of death. These challenges call for attack from various angles, coordinated efforts, rational strategies, initiatives throughout the cancer trajectory, activities to reduce inequities, and implementation of evidence-based measures. In order to defeat the societal challenges of cancer through innovation, Europe will need to join forces and connect the European Commission and the member states, politicians and citizens, industries and patient associations. A cancer mission should thus unite the public and patient viewpoint to the perspective of cancer professionals. The authors describe a plan that has been agreed upon among some of the major European Cancer organizations and associations. This plan uses a cancer mission as a tool and must deliver robust medical evidence to patients and doctors through high-quality research delivering sustainable and affordable strategies for prevention, treatment, and follow-up.
- Published
- 2019
- Full Text
- View/download PDF
7. Cancer precision medicine today: Towards omic information in healthcare systems.
- Author
-
Maggi N, Gazzarata R, Ruggiero C, Lombardo C, and Giacomini M
- Subjects
- Delivery of Health Care methods, Electronic Health Records, Humans, Precision Medicine methods, Semantics, Software, Neoplasms drug therapy, Neoplasms therapy
- Abstract
Introduction:: This article focuses on the integration of omics data in electronic health records and on interoperability aspects relating to big data analysis for precision medicine., Methods:: Omics data integration methods for electronic health record and for systems interoperability are considered, with special reference to the high number of specific software tools used to manage different aspects of patient treatment. This is an important barrier against the use of this integrated approach in daily clinical routine., Results:: The correct use of all three levels of interoperability (technical, semantic, and process interoperability) plays a key role in order to achieve an easy access to a significant amount of data, all with correct contextualization, which is the only way to obtain a real value from data for precision medicine., Conclusions:: The proposed architecture could improve the potentialities of data routinely collected in many health information systems to form a real patient center information environment.
- Published
- 2019
- Full Text
- View/download PDF
8. Genetic alterations in sporadic triple negative breast cancer.
- Author
-
Pop LA, Cojocneanu-Petric RM, Pileczki V, Morar-Bolba G, Irimie A, Lazar V, Lombardo C, Paradiso A, and Berindan-Neagoe I
- Subjects
- Adult, Aged, Biomarkers, Tumor genetics, Female, Genes, BRCA1, Genes, BRCA2, Humans, Kaplan-Meier Estimate, Middle Aged, Polymorphism, Genetic, Prognosis, Proto-Oncogene Proteins c-akt genetics, Proto-Oncogene Proteins c-kit genetics, Retrospective Studies, Tumor Suppressor Protein p53 genetics, Vascular Endothelial Growth Factor Receptor-2 genetics, BRCA1 Protein genetics, BRCA2 Protein genetics, Breast Neoplasms genetics, Triple Negative Breast Neoplasms genetics
- Abstract
Background: Recent studies have aimed to identify gene mutation profiles to explain the cause of TNBC therapy limitations., Methods: The purpose of our study was to use Next Generation Sequencing (NGS) of 46 genes with a well-defined role in cancer in a cohort of TNBC patients in order to identify novel markers that could lead to the development of strategic, adjuvant, gene-targeted therapies., Results: A total of 118 gene mutations in 35 genes, 75 mutations in BRCA1 and 92 mutations in BRCA2 were identified. The clinical assessment of the identified mutations showed 27 to be possibly damaging and 59 to be damaging. TP53, KDR, PIK3CA (rs3729687), ATM, AKT1 and KIT were among the most frequently mutated genes in our TNBC cohort. The SNP AKT1 (rs3730358) was suggested to modify the risk of breast cancer. SNP PIK3CA (rs3729687) is a damaging mutation that we found to be correlated with the prognosis of TNBC. The survival curve analysis showed that the presence of AKT1, TP53, KDR, KIT, BRCA1 and BRCA2 mutations is correlated with a poor prognosis., Conclusion: We show a strong association between TNBC and mutations in BRCA1/2 genes and the poor outcome of these patients. Moreover, we identified several other unknown mutations putatively associated with the poor prognosis of TNBC tumors. We also discovered novel mutations never before associated with breast cancer that could putatively account for the poor prognosis of the TNBC tumors., (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
9. Piloting a generic cancer consumer quality index in six European countries.
- Author
-
Wind A, Roeling MP, Heerink J, Sixma H, Presti P, Lombardo C, and van Harten W
- Subjects
- Adult, Aged, Europe, Female, Humans, Hungary, Italy, Lithuania, Male, Middle Aged, Netherlands, Pilot Projects, Portugal, Quality Indicators, Health Care, Romania, Surveys and Questionnaires, Young Adult, Neoplasms psychology, Patient Satisfaction statistics & numerical data, Psychometrics methods
- Abstract
Background: Accounting for patients' perspective has become increasingly important. Based on the Consumer Quality Index method (founded on Consumer Assessment of Healthcare Providers and Systems) a questionnaire was recently developed for Dutch cancer patients. As a next step, this study aimed to adapt and pilot this questionnaire for international comparison of cancer patients experience and satisfaction with care in six European countries., Method: The Consumer Quality Index was translated into the local language at the participating pilot sites using cross-translation. A minimum of 100 patients per site were surveyed through convenience sampling. Data from seven pilot sites in six countries was collected through an online and paper-based survey. Internal consistency was tested by calculating Cronbach's alpha and validity by means of cognitive interviews. Demographic factors were compared as possible influencing factors., Results: A total of 698 patients from six European countries filled the questionnaire. Cronbach's alpha was good or satisfactory in 8 out of 10 categories. Patient satisfaction significantly differed between the countries. We observed no difference in patient satisfaction for age, gender, education, and tumor type, but satisfaction was significantly higher in patients with a higher level of activation., Conclusion: This European Cancer Consumer Quality Index(ECCQI) showed promising scores on internal consistency (reliability) and a good internal validity. The ECCQI is to our knowledge the first to measure and compare experiences and satisfaction of cancer patients on an international level, it may enable healthcare providers to improve the quality of cancer care.
- Published
- 2016
- Full Text
- View/download PDF
10. Nutritional Online Information for Cancer Patients: a Randomized Trial of an Internet Communication Plus Social Media Intervention.
- Author
-
Gnagnarella P, Misotti AM, Santoro L, Akoumianakis D, Del Campo L, De Lorenzo F, Lombardo C, Milolidakis G, Sullivan R, and McVie JG
- Subjects
- Case-Control Studies, Early Intervention, Educational, Female, Humans, Male, Middle Aged, Power, Psychological, Surveys and Questionnaires, Communication, Internet statistics & numerical data, Neoplasms prevention & control, Nutrition Therapy, Patient Education as Topic, Quality of Life, Social Media statistics & numerical data
- Abstract
We hypothesized that cancer patients using an Internet website would show an improvement in the knowledge about healthy eating habits, and this might be enhanced by social media interaction. A 6-month randomized intervention was set up. Eligible subjects were allocated in intervention (IG) and control groups (CG). IG had access to the website, and CG was provided with printed versions. All enrolled participants filled in Nutrition Questionnaire (NQ), Quality of Life Questionnaire (QoL) and Psychological Distress Inventory (PDI), at baseline and after 6 months. The difference between post- vs pre-questionnaires was calculated. Seventy-four subjects (CG 39; IG 35) completed the study. There was an increase in the score after the intervention in both groups for the NQ, even if not statistically significant. Dividing the IG into three categories, no (NI), low (LI) and high interactions (HI), we found a decreased score (improvement) in the CG (-0.2) and in the HI (-1.7), and an increased score (worsening) in the NI (+3.3) (p = NS) analysing the PDI. We found an increased score in the QoL both in CG and IG (adjusted LSMeans +3.5 and +2.8 points, respectively; p = NS). This study represents an example for support cancer patients. Despite the lack of significant effects, critical points and problems encountered may be of interest to researchers and organization working in the cancer setting. Intervention strategies to support patients during the care process are needed in order to attain the full potential of patient-centred care on cancer outcomes.
- Published
- 2016
- Full Text
- View/download PDF
11. Participation of Italian Cancer Centres of the Alleanza Contro Il Cancro (ACC) in the Organisation of European Cancer Institutes (OECI) Accreditation and Designation program: a successful first national initiative.
- Author
-
Oberst S, Boomsma F, Lombardo C, Docter M, Blaauwgeers H, De Paoli P, de Valeriola D, Paradiso A, and Saghatchian M
- Subjects
- Europe, Humans, International Cooperation, Italy, Neoplasms diagnosis, Neoplasms therapy, Accreditation, Cancer Care Facilities standards, Interdisciplinary Communication, Patient Care Team, Quality Improvement
- Abstract
The Organisation of European Cancer Institutes (OECI) launched a program for accreditation and designation (A&D) of cancer centers in Europe based on voluntary participation in 2008. In 2012, the Italian Ministry of Health decided to fund cancer centers in Italy, members of the Alleanza Contro il Cancro (ACC), to go through the OECI accreditation program. Ten centers participated in the program and 10 completed the full cycle of the OECI A&D process in consecutive series over a 2-year period. The process was successfully completed within the planned timeline and the overall findings were presented to the Italian Ministry of Health and representatives of all the participating centers in November 2015. The program had a considerable team-building effect, which will likely continue as the improvement plans are implemented. Centers fed back to OECI that the A&D program had led to better formal organization of multidisciplinary teams (MDTs) and cancer care pathways, and had helped them to harmonize the integration of research into clinical practice. Centers also concluded that they benefited from recognition through an international accreditation system, and that it had led to them developing better patient information and involvement. The importance of the improvement plans that each center had to produce following the audit reviews cannot be underestimated. The OECI concludes that implementation of the A&D program at the national level is feasible despite national peculiarities related to health planning and organization in each member state. This is a good example of an EU project working well, with member states helping each other and learning from best practice, to improve the overall quality of cancer care and research and to establish consistency. The initial accreditation is the first part of an ongoing process of improving comprehensive cancer care, integrating bench to bedside.
- Published
- 2015
- Full Text
- View/download PDF
12. Report from the OECI Oncology Days 2014.
- Author
-
van Harten W, Stanta G, Bussolati G, Riegman P, Hoefler G, Becker K, Folprecht G, Truini M, Haybaeck J, Buiga R, Dono M, Bagg A, López Guerrero J, Zupo S, Lemare F, de Lorenzo F, Goedbloed N, Razavi D, Lövey J, Cadariu P, Rollandi G, Paparo F, Pierotti M, Ciuleanu T, De Paoli P, Weiner G, Saghatchian M, and Lombardo C
- Abstract
The 2014 OECI Oncology Days was held at the 'Prof. Dr. Ion Chiricuta' Oncology Institute in Cluj, Romania, from 12 to 13 June. The focus of this year's gathering was on developments in personalised medicine and other treatment advances which have made the cost of cancer care too high for many regions throughout Europe.
- Published
- 2014
- Full Text
- View/download PDF
13. Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation program.
- Author
-
Saghatchian M, Thonon F, Boomsma F, Hummel H, Koot B, Harrison C, Rajan A, de Valeriola D, Otter R, Laranja Pontes J, Lombardo C, McGrath E, Ringborg U, Tursz T, and van Harten W
- Subjects
- Accreditation, Cancer Care Facilities organization & administration, Critical Pathways, Europe, Medical Oncology education, Medical Oncology organization & administration, Quality of Health Care, Surveys and Questionnaires, Cancer Care Facilities standards, Medical Oncology standards, Neoplasms therapy, Quality Assurance, Health Care
- Abstract
Purpose: In order to improve the quality of care in Cancer Centers (CC) and designate Comprehensive Cancer Centers (CCCs), the Organization for European Cancer Institutes (OECI) launched an Accreditation and Designation (A&D) program. The program facilitates the collection of defined data and the assessment of cancer center quality. This study analyzes the results of the first 10 European centers that entered the program., Methods: The assessment included 927 items divided across qualitative and quantitative questionnaires. Data collected during self-assessment and peer-review from the 10 first participating centers were combined in a database for comparative analysis using simple statistics. Quantitative and qualitative results were validated by auditors during the peer review visits., Results: Volumes of various functions and activities dedicated to care, research, and education varied widely among centers. There were no significant differences in resources for radiology, radiotherapy, pathologic diagnostic, and surgery. Differences were observed in the use of clinical pathways but not for the practices of holding multidisciplinary team meetings and conforming to guidelines. Regarding human resources, main differences were in the composition and number of supportive care and research staff. All 10 centers applied as CCCs; five obtained the label, and five were designated as CCs., Conclusion: The OECI A&D program allows comparisons between centers with regard to management, research, care, education, and designation as CCs or CCCs. Through the peer review system, recommendations for improvements are given. Assessing the added value of the program, as well as research and patient treatment outcomes, is the next step., (Copyright © 2014 by American Society of Clinical Oncology.)
- Published
- 2014
- Full Text
- View/download PDF
14. Policy statement on multidisciplinary cancer care.
- Author
-
Borras JM, Albreht T, Audisio R, Briers E, Casali P, Esperou H, Grube B, Hamoir M, Henning G, Kelly J, Knox S, Nabal M, Pierotti M, Lombardo C, van Harten W, Poston G, Prades J, Sant M, Travado L, Valentini V, van de Velde C, van den Bogaert S, van den Bulcke M, van Hoof E, van den Neucker I, and Wilson R
- Subjects
- Consensus, Europe, Health Care Sector, Humans, Patient-Centered Care standards, Health Policy, Medical Oncology standards, Neoplasms therapy
- Abstract
Background: Cancer care is undergoing an important paradigm shift from a disease-focused management to a patient-centred approach, in which increasingly more attention is paid to psychosocial aspects, quality of life, patients' rights and empowerment and survivorship. In this context, multidisciplinary teams emerge as a practical necessity for optimal coordination among health professionals and clear communication with patients. The European Partnership for Action Against Cancer (EPAAC), an initiative launched by the European Commission in 2009, addressed the multidisciplinary care from a policy perspective in order to define the core elements that all tumour-based multidisciplinary teams (MDTs) should include. To that effect, a working group conference was held in January 2013 within the EPAAC Work Package 7 (on Healthcare) framework., Methods: The consensus group consisted of high-level representatives from the following European scientific societies, patient associations and stakeholders: European CanCer Organisation (ECCO), European SocieTy for Radiology & Oncology (ESTRO), European Society for Medical Oncology (ESMO), European Society of Surgical Oncology (ESSO), International Society of Geriatric Oncology (SIOG), European Association for Palliative Care (EAPC), European Oncology Nursing Society (EONS), International Psycho-Oncology Society (IPOS),European Cancer Patient Coalition (ECPC), EuropaColon, Europa Donna - The European Breast Cancer Coalition, Association of European Cancer Leagues (ECL), Organisation of European Cancer Institutes (OECI), EUSOMA - European Society of Breast Cancer Specialists, European Hospital and Healthcare Federation (HOPE) and EPAAC Work Packages 5 (Health promotion and prevention), 7, 8 (Research), 9 (Information systems) and 10 (Cancer plans). A background document with a list of 26 core issues drawn from a systematic review of the literature was used to guide the discussion. Five areas related to MDTs were covered: care objectives, organisation, clinical assessment, patients' rights and empowerment and policy support. Preliminary drafts of the document were widely circulated for consultation and amendments by the working group before final approval., Results: The working group unanimously formulated a Policy Statement on Multidisciplinary Cancer Care to define the core elements that should be implemented by all tumour-based MDTs. This document identifies MDTs as the core component in cancer care organisation and sets down the key elements to guide changes across all European health systems., Conclusion: MDTs are an essential instrument of effective cancer care policy, and their continued development crucial to providing patients the care they need and deserve. While implementation must remain in local hands, European health systems can still benefit from having a basis for an effective multidisciplinary model of cooperation. This policy statement is intended to serve as a reference for policymakers and healthcare providers who wish to improve the services currently provided to the cancer patients whose lives and well-being depend on their action., (Copyright © 2013 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
15. A semi-automatic web based tool for the selection of research projects reviewers.
- Author
-
Pupella V, Monteverde ME, Lombardo C, Belardelli F, and Giacomini M
- Subjects
- Decision Making, PubMed, Artificial Intelligence, Internet, Medical Subject Headings, Peer Review, Research methods, Periodicals as Topic classification, Personnel Selection methods, Software
- Abstract
The correct evaluation of research proposals continues today to be problematic, and in many cases, grants and fellowships are subjected to this type of assessment. A web based semi-automatic tool to help in the selection of reviewers was developed. The core of the proposed system is the matching of the MeSH Descriptors of the publications submitted by the reviewers (for their accreditation) and the Descriptor linked to the research keywords, which were selected. Moreover, a citation related index was further calculated and adopted in order to discard not suitable reviewers. This tool was used as a support in a web site for the evaluation of candidates applying for a fellowship in the oncology field.
- Published
- 2014
16. Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers.
- Author
-
Deriu PL, La Pietra L, Pierotti M, Collazzo R, Paradiso A, Belardelli F, De Paoli P, Nigro A, Lacalamita R, Ferrarini M, Pelicci P, Pierotti M, Roli A, Ciliberto G, Scala S, Amadori A, Chiusole D, Musto P, Fusco V, Storto G, De Maria R, Canitano S, Apolone G, Ravelli M, Mazzini E, Amadori D, Bernabini M, Ancarani V, and Lombardo C
- Subjects
- Clinical Competence, Critical Pathways, Government Agencies, Health Personnel, Humans, Inservice Training, Internationality, Italy, Peer Review, Quality Control, Research Personnel, Social Responsibility, Accreditation, Benchmarking, Biomedical Research organization & administration, Biomedical Research standards, Biomedical Research trends, Cancer Care Facilities standards, Quality of Health Care
- Abstract
A panel of experts from Italian Comprehensive Cancer Centers defines the recommendations for external quality control programs aimed to accreditation to excellence of these institutes. After definition of the process as a systematic, periodic evaluation performed by an external agency to verify whether a health organization possesses certain prerequisites regarding structural, organizational and operational conditions that are thought to affect health care quality, the panel reviews models internationally available and makes final recommendations on aspects considered of main interest. This position paper has been produced within a special project of the Ministry of Health of the Italian Government aimed to accredit, according to OECI model, 11 Italian cancer centers in the period 2012-2014. The Project represents the effort undertaken by this network of Comprehensive Cancer Centers to find a common denominator for the experience of all Institutes in external quality control programs. Fourteen shared "statements" are put forth, designed to offer some indications on the main aspects of this subject, based on literature evidence or expert opinions. They deal with the need for "accountability" and involvement of the entire organization, the effectiveness of self-evaluation, the temporal continuity and the educational value of the experience, the use of indicators and measurement tools, additionally for intra- and inter-organization comparison, the system of evaluation models used, the provision for specific requisites for oncology, and the opportunity for mutual exchange of evaluation experiences.
- Published
- 2013
- Full Text
- View/download PDF
17. Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study.
- Author
-
Allemani C, Rachet B, Weir HK, Richardson LC, Lepage C, Faivre J, Gatta G, Capocaccia R, Sant M, Baili P, Lombardo C, Aareleid T, Ardanaz E, Bielska-Lasota M, Bolick S, Cress R, Elferink M, Fulton JP, Galceran J, Gózdz S, Hakulinen T, Primic-Zakelj M, Rachtan J, Diba CS, Sánchez MJ, Schymura MJ, Shen T, Tagliabue G, Tumino R, Vercelli M, Wolf HJ, Wu XC, and Coleman MP
- Abstract
Objectives: To assess the extent to which stage at diagnosis and adherence to treatment guidelines may explain the persistent differences in colorectal cancer survival between the USA and Europe., Design: A high-resolution study using detailed clinical data on Dukes' stage, diagnostic procedures, treatment and follow-up, collected directly from medical records by trained abstractors under a single protocol, with standardised quality control and central statistical analysis., Setting and Participants: 21 population-based registries in seven US states and nine European countries provided data for random samples comprising 12 523 adults (15-99 years) diagnosed with colorectal cancer during 1996-1998., Outcome Measures: Logistic regression models were used to compare adherence to 'standard care' in the USA and Europe. Net survival and excess risk of death were estimated with flexible parametric models., Results: The proportion of Dukes' A and B tumours was similar in the USA and Europe, while that of Dukes' C was more frequent in the USA (38% vs 21%) and of Dukes' D more frequent in Europe (22% vs 10%). Resection with curative intent was more frequent in the USA (85% vs 75%). Elderly patients (75-99 years) were 70-90% less likely to receive radiotherapy and chemotherapy. Age-standardised 5-year net survival was similar in the USA (58%) and Northern and Western Europe (54-56%) and lowest in Eastern Europe (42%). The mean excess hazard up to 5 years after diagnosis was highest in Eastern Europe, especially among elderly patients and those with Dukes' D tumours., Conclusions: The wide differences in colorectal cancer survival between Europe and the USA in the late 1990s are probably attributable to earlier stage and more extensive use of surgery and adjuvant treatment in the USA. Elderly patients with colorectal cancer received surgery, chemotherapy or radiotherapy less often than younger patients, despite evidence that they could also have benefited.
- Published
- 2013
- Full Text
- View/download PDF
18. Cancer research performance in the European Union: a study of published output from 2000 to 2008.
- Author
-
Micheli A, Di Salvo F, Lombardo C, Ugolini D, Baili P, and A Pierotti M
- Subjects
- Animals, Bibliometrics, China, Developing Countries statistics & numerical data, Humans, Japan, Periodicals as Topic standards, Publishing, Research Support as Topic, United States, European Union, Gross Domestic Product, Journal Impact Factor, Neoplasms, Periodicals as Topic statistics & numerical data, Research trends
- Abstract
Aims and Background: Although several studies have assessed cancer research performance in individual European countries, comparisons of European Union (EU27) performance with countries of similar population size are not available., Methods: We compared cancer research performance in 2000-2008 between EU27 and 11 countries with over 100 million inhabitants. Performance should not have been affected by the 2007-2009 recession. We examined 143 journals considered oncology journals by Journal Citation Reports, accessing them via Scopus. Publications were attributed to countries using a published counting procedure., Results: For number of publications, the USA held a clear lead in 2006-2008 (yearly averages: 10,293 USA vs 9,962 EU27), whereas the EU27 held the lead previously. EU27 was also second to the USA for total impact factor. China markedly improved its cancer publications record over the period. Compared to the USA, EU27 and Japan, the other countries (all developing) had a poor publications record., Conclusions: Comparative cancer research spending data are not available. However from 2002 to 2007, gross domestic expenditure on research and development (UNESCO data) increased by 34% in North America, 161% in China and only 28% in EU27. Thus the European Union is lagging behind North America and may well be eclipsed by China in research and development spending in the near future. We suggest that these new findings should be considered by policymakers in Europe and other countries when developing policies for cancer control.
- Published
- 2011
- Full Text
- View/download PDF
19. TRAIN: Training through Research Application Italian iNitiative.
- Author
-
Lombardo C, Bottero S, d'Alessandro F, Giacomini M, Guderzo A, Moretti F, Marincola M, Pesce G, Pierotti MA, Spagnoli LG, and Belardelli F
- Subjects
- Fellowships and Scholarships, Humans, Italy, Translational Research, Biomedical economics, Workforce, Neoplasms diagnosis, Neoplasms genetics, Neoplasms therapy, Translational Research, Biomedical education
- Abstract
Training through Research Application Italian iNitiative (TRAIN) is a mobility program financed under the EU action called "Cofinancing of regional, national and international programs" (COFUND) of the European Commission Seventh Framework Program (FP7) - People, and has been designed to encourage the promotion and development of international programs of research through mobility at various stages of research careers. The aim of TRAIN is to improve translational skills in the field of cancer by promoting a three-year international mobility program assigning a total of 51 fellowships subdivided into incoming, outgoing and reintegration fellowships.?The TRAIN proposal has been submitted in February 2009 to the European Commission in reply to the 2008 FP7-PEOPLE-COFUND call and has been successfully evaluated. TRAIN is addressed to postdoctoral scientists or scientists who have at least four years' full-time equivalent research experience and who wish to improve their careers spending one year abroad. The mobility program is open also to non-Italian experienced scientists wishing to spend one year in an Italian research center or private company. Part of the scheme is targeted to experienced Italian scientists who have completed at least three years of research in a foreign country and are interested in returning to Italy.?TRAIN is part of an overall Italian strategy outlined by the International Program of the Italian Cancer Network "Alleanza Contro il Cancro" to promote Italian participation in the building of the European Area for translational cancer research and to enhance the interaction between academy and industry.
- Published
- 2011
- Full Text
- View/download PDF
20. CIGNOweb.it.
- Author
-
Truccolo I, Bogliolo A, Ricci R, Giacomini M, Pivetti S, Russell-Edu W, De Lorenzo F, Della Seta M, Colombo C, Bufalino R, Bocchini G, Pierotti M, Lombardo C, and De Paoli P
- Subjects
- Humans, Italy, Databases, Factual standards, Databases, Factual trends, Information Dissemination methods, Internet, Medical Oncology
- Abstract
We introduce CIGNOweb.it, a database of oncology resources for patients, the general public and healthcare professionals. It builds on the previous Italian cancer resource Azaleaweb and offers quality-evaluated content. It meets international bibliographic and technical standards such as the Open Archives Initiative (OAI) for web content interoperability and the Functional Requirements for Bibliographic Records (FRBR) for bibliographic description with respect to the different media, applications, and user needs. Database content is supplied in collaboration with non-profit associations, libraries and the network of Cancer Information Points that is currently being established all over Italy. Expert and customer evaluation and feedback are provided for in the system. The graphic layout has been painstakingly designed to be user-friendly for a non-expert public. CIGNOweb.it is multicentric and will in time offer health information outside the field of oncology. It is designed to become a multilingual tool to organize, optimize and access patient information produced in the languages of the "newer" European countries. It is hoped that CIGNOweb.it will support other European nations in enhancing the structure and organization of their own-language patient health information and will contribute towards making a common health information portal of the European Union a reality.
- Published
- 2011
- Full Text
- View/download PDF
21. Research trends for early cancer biomarker detection in Italy: an integrated program in oncology (PIO) survey.
- Author
-
Verderio P, Mangia A, Orlando C, Belfiglio M, Marchetti A, Bertario L, Chiappetta G, Gion M, Tonini GP, Podo F, Vocaturo A, Silvestrini R, Lombardo C, and Paradiso A
- Subjects
- Critical Pathways, Early Detection of Cancer, Humans, Italy, Program Development, Reproducibility of Results, Surveys and Questionnaires, Biomarkers, Tumor blood, Biomedical Research trends, Neoplasms blood, Neoplasms diagnosis
- Abstract
Aims and Background: In 2007, an Italian Research Network proposed to the Ministry of Health a concerted action aimed at developing a specific pathway for the analytical and clinical validation of new biomarkers for early cancer diagnosis. The action, funded by the Italian Ministry of Health within the Integrated Program in Oncology (PIO) and coordinated by the National Cancer Institute of Bari, started in 2008 involving 37 national research teams., Methods: To monitor the methodological and analytical needs of the studies proposed by the research teams of PIO as well as to explore the plausibility of planning external quality assessment programs for early cancer biomarker detection, the coordinating team developed an ad hoc questionnaire that was submitted to each research team., Results: From the collected data it emerged that about 70% of the biomarkers under investigation were analyzed according to nonroutine laboratory practices. The biological material utilized for biomarker assessment consisted of solid tissue (normal or pathological) in 31% of studies, serum in 21%, urine in 15%, plasma in 15%, and whole blood in 11%. Specific training of personnel directly involved in the program was reported by 18% of the teams. In 2008, only 6% of laboratories involved in PIO participated in both external quality assessment and internal quality control schemes specifically designed for the biomarkers under consideration. Standard operating procedures for the determination of about half (52%) of the biomarkers proved to be lacking in at least one phase of the biomarker assessment process., Conclusions: On the basis of these results, we decided to give priority to the application of a four-phase process for the analytical validation of new potential biomarkers by setting up and applying standard operating procedures and developing external quality assessment and internal quality control schemes as specific steps of the workflow.
- Published
- 2010
- Full Text
- View/download PDF
22. Meeting Report: Hereditary Breast and Ovarian Cancer (HBOC): Risks and Challenges. September 10-12, 2009 Bari, Italy.
- Author
-
Paradiso A, Tommasi S, Pilato B, Lombardo C, Smith J, and Muggia F
- Published
- 2009
- Full Text
- View/download PDF
23. International collaborations in cancer control and the Third International Cancer Control Congress.
- Author
-
Micheli A, Sanz N, Mwangi-Powell F, Coleman MP, Neal C, Ullrich A, Travado L, Santini LA, Grassi L, De Lorenzo F, Costa A, Dangou JM, Bisanti L, Seniori Costantini A, Abu-Rmeileh N, Kamal M, Federico M, Saracci R, Rennert G, Stefanini A, Cavalli F, Cazap E, Redmond K, O'Reilly S, Muti P, Casali P, Gatta G, Ferrari A, Koifman S, Bah E, Pastore G, Barr R, Lombardo C, Frazzingaro C, Ciampichini R, and Baili P
- Subjects
- Adolescent, Africa, Caribbean Region, Congresses as Topic, European Union statistics & numerical data, Female, Humans, Latin America, Primary Prevention methods, Survival Analysis, Telemedicine, Uterine Cervical Neoplasms prevention & control, Vaginal Smears, Young Adult, Global Health, International Cooperation, Neoplasms diagnosis, Neoplasms mortality, Neoplasms prevention & control
- Abstract
Over the past few decades, there has been growing support for the idea that cancer needs an interdisciplinary approach. Therefore, the international cancer community has developed several strategies as outlined in the WHO non-communicable diseases Action Plan (which includes cancer control) as the World Health Assembly and the UICC World Cancer Declaration, which both include primary prevention, early diagnosis, treatment, and palliative care. This paper highlights experiences/ideas in cancer control for international collaborations between low, middle, and high income countries, including collaborations between the European Union (EU) and African Union (AU) Member States, the Latin-American and Caribbean countries, and the Eastern Mediterranean countries. These proposals are presented within the context of the global vision on cancer control set forth by WHO in partnership with the International Union Against Cancer (UICC), in addition to issues that should be considered for collaborations at the global level: cancer survival (similar to the project CONCORD), cancer control for youth and adaptation of Clinical Practice Guidelines. Since cancer control is given lower priority on the health agenda of low and middle income countries and is less represented in global health efforts in those countries, EU and AU cancer stakeholders are working to put cancer control on the agenda of the EU-AU treaty for collaborations, and are proposing to consider palliative care, population-based cancer registration, and training and education focusing on primary prevention as core tools. A Community of Practice, such as the Third International Cancer Control Congress (ICCC-3), is an ideal place to share new proposals, learn from other experiences, and formulate new ideas. The aim of the ICCC-3 is to foster new international collaborations to promote cancer control actions in low and middle income countries. The development of supranational collaborations has been hindered by the fact that cancer control is not part of the objectives of the Millennium Development Goals (MGGs). As a consequence, less resources of development aids are allocated to control NCDs including cancer.
- Published
- 2009
- Full Text
- View/download PDF
24. Comparative cancer survival information in Europe.
- Author
-
Berrino F, Verdecchia A, Lutz JM, Lombardo C, Micheli A, and Capocaccia R
- Subjects
- Europe epidemiology, Female, Health Policy, Humans, Male, Publications statistics & numerical data, Survival Analysis, Neoplasms mortality
- Published
- 2009
- Full Text
- View/download PDF
25. Italian performance in cancer research.
- Author
-
Micheli A, Di Salvo F, Lombardo C, Ciampichini R, Ugolini D, Baili P, and Pierotti MA
- Subjects
- Animals, Bibliometrics, Humans, Italy, Journal Impact Factor, Journalism, Medical, Neoplasms, Research statistics & numerical data, Research Support as Topic economics
- Abstract
Aims and Background: Italian performance in cancer research from 2000 to 2007 was assessed and compared to that of the other 19 wealthiest countries in the world which carry out the bulk of cancer research., Methods: Performance was evaluated quantitatively as the number of publications in 125 journals indexed as 'oncological' by Journal Citation Reports and qualitatively as the total impact factor (TIF). Number of publications and TIF were adjusted for the population and gross domestic product (GDP) of each country. The Scopus database was used as publication source., Results: Italy ranked 5th, with the US ranking 1st, over the entire study period for number of cancer publications, which increased over that period. Italy ranked 4th in 2006-2007 for GDP-adjusted and 5th for population-adjusted publication number, loosing ground in the GDP-adjusted ranking and gaining ground in the population-adjusted ranking over the study period. When the quality of research publications was considered, in 2006-2007 Italy was in 5th place for crude TIF (US 1st), in 4th place for GDP-adjusted TIF (Sweden 1st), and in 6th place for population-adjusted TIF (Sweden 1st). Over the study period, Italy was stable for crude and population-adjusted TIF but declined somewhat for GDP-adjusted TIF., Conclusions: Italy's performance in cancer research over the eight years to 2008 was better than expected considering its GDP and population. Nevertheless, the slight decline evidenced by the present study should induce scientists and policy makers to find ways to reverse the situation.
- Published
- 2009
- Full Text
- View/download PDF
26. Nanotechnology: going small for a giant leap in cancer diagnostics and therapeutics.
- Author
-
Pierotti MA, Lombardo C, and Rosano C
- Subjects
- Animals, Drug Delivery Systems, Humans, Nanostructures, Drug Carriers, Nanotechnology, Neoplasms diagnosis, Neoplasms therapy
- Abstract
"There is Plenty of Room at the Bottom"--not just "There is Room at the Bottom."What I have demonstrated is that there is room--that you can decrease the size of things in a practical way. I now want to show that there is plenty of room. Richard Feynman, December 29, 1959. More than 30 years ago Richard Feynman pointed out that physicists knew no limits to prevent us from doing engineering at the level of atoms. Until recently, though, while the lack of physical limits was accepted as commonplace, molecular engineering was thought of as impractical, unnecessary, or requiring breakthroughs in knowledge and technique that placed it somewhere in the distant future. Many visionaries intimately familiar with the development of silicon technology still forecast it would take between 20 and 50 years before molecular engineering became a reality. This is well beyond the planning horizon of most companies. But recently, everything has begun to change. After the industrial revolution and the "computer age", are we really facing a new era?
- Published
- 2008
- Full Text
- View/download PDF
27. Improvement of European translational cancer research. Collaboration between comprehensive cancer centers.
- Author
-
Ringborg U, de Valeriola D, van Harten W, Bosch AL, Lombardo C, Nilsson K, Philip T, Pierotti MA, Riegman P, Saghatchian M, Storme G, Tursz T, and Verellen D
- Subjects
- Chronic Disease, Humans, Organizations, Nonprofit, Prevalence, Biomedical Research, Cancer Care Facilities trends, Cooperative Behavior, European Union, Neoplasms epidemiology, Neoplasms prevention & control, Neoplasms therapy
- Abstract
Even though the increasing incidence of cancer is mainly a consequence of a population with a longer life span, part of this augmentation is related to the increasing prevalence of patients living with a chronic cancer disease. To fight the problem, improved preventive strategies are mandatory in combination with an innovative health care provision that is driven by research. To overcome the weakness of translational research the OECI is proposing a practical approach as part of a strategy foreseen by the EUROCAN+PLUS feasibility study, which was launched by the EC in order to identify mechanisms for the coordination of cancer research in Europe.
- Published
- 2008
- Full Text
- View/download PDF
28. Biotherapy of cancer: break the barriers to foster translation of knowledge.
- Author
-
Ferrantini M, Lombardo C, Moretti F, and Belardelli F
- Subjects
- Academies and Institutes, Animals, Biological Therapy, Cooperative Behavior, Disease Models, Animal, Europe, Humans, Italy, Neoplasms immunology, Program Development, Biomedical Research trends, Community Networks, Immunotherapy, Neoplasms therapy
- Abstract
Biotherapy of cancer holds great promise for its potential to lead to the identification of novel, selective, and effective treatments against cancer. However, the clinical development of biopharmaceuticals and biotherapy products is hampered by several and diverse barriers. Herein, we will address some of the critical issues identified both at the national and European level as the major obstacles for the translation of knowledge into clinical applications in the field of biotherapy and immunotherapy of cancer. We will also illustrate specific initiatives undertaken both in Europe and in Italy in order to support the translational and clinical research and that are expected to have a favorable impact on the process of clinical development of novel and more effective therapeutic interventions against cancer. The contents of this article are directly referred to the event "International Clinical Trials' Day on Biotherapy of Cancer" organized in the context of the OECI Genoa 2008, with the sponsorship of Alliance Against Cancer (ACC) and the Istituto Superiore di Sanità (ISS, the Italian National Institute of Health), and under the auspices of the European Clinical Research Infrastructures Network (ECRIN). This event sees the active participation of representatives of the ISS and of the Italian Network for Tumor Biotherapy, both involved in a project recently funded by ACC and aimed at the promotion of clinical research in the field of cancer biotherapy and immunotherapy, through the creation of a national network of clinical cancer research centers and GMP facilities dedicated to the production of biological drugs and advanced medicinal products.
- Published
- 2008
- Full Text
- View/download PDF
29. Training and mobility: a priority for the Organisation of the European Cancer Institutes. How a national mobility initiative could enhance EU cooperation in cancer research contributing to the development of an European Research Area: the example of The Italian Comprehensive Cancer Centers' Network "Alleanza Contro il Cancro".
- Author
-
Lombardo C, Albanese D, Belardelli F, d'Alessandro F, Giacomini M, Rondanina T, and Spagnoli LG
- Subjects
- Academies and Institutes, Emigration and Immigration, European Union, Humans, Italy, Program Development, Program Evaluation, Research Support as Topic, Workforce, Biomedical Research organization & administration, Biomedical Research trends, Cancer Care Facilities trends, Career Mobility, Cooperative Behavior, Education, Medical, Continuing, Neoplasms
- Abstract
It is widely recognized that productivity gains, sustained economic growth and employment are largely determined by technological progress, innovation and human capital. The 2000 Lisbon strategy to make Europe a competitive knowledge-based economy by 2010 and, more specifically, the Barcelona objectives agreed upon in 2002 to increase R&D investment in the EU to approach 3% of GDP, ensuring that there are sufficient human resources for research, are a preliminary step in this direction. If we want to reach this goal we have to succeed in retaining the best researchers, creating the right environment where they can perform their activities and develop their careers. To this aim the Organization of European Cancer Institutes (OECI) has set up a working group on Education and Training with the mandate to encourage continuing education in cancer research and applications and to verify the feasibility to promote mobility programs inside the network and in association with industries. Until now only few OECI training programs have been launched and a full mobility program has not been developed yet due to limited budget resources. The Italian Network of Comprehensive Cancer Centers, Alleanza Contro il Cancro, has planned the launch of a mobility program awarding 70 annual fellowships over a period of 36 months. This program, which will be open to the world research community, could represent a first interaction through mobility among the members of the OECI network also involving industries. The program is a tangible approach to sustain the translational process needed for the development of an European Research Area in the field of cancer and its related biomedical disciplines, thus providing a practical answer to the 2005 renewed Lisbon Strategy.
- Published
- 2008
- Full Text
- View/download PDF
30. 45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003.
- Author
-
Giavazzi R, Aglietta M, Astolfi A, Falanga A, Fusco A, Labianca R, Lollini PL, Lombardo C, Natali PG, Pierotti MA, Presta M, Santoro M, Taraboletti G, Zupi G, and Vecchio G
- Subjects
- Anticarcinogenic Agents therapeutic use, Biomedical Research, Combined Modality Therapy, Europe, Humans, Inflammation complications, Italy, Neoplasm Invasiveness, Neoplasm Metastasis, Neovascularization, Pathologic, Oncogenes, Proteomics, Societies, Medical, Medical Oncology, Neoplasms etiology, Neoplasms therapy
- Abstract
The 45th Annual Meeting of the Italian Cancer Society (SIC), held at the Centro Congressi Giovanni XXIII in Bergamo, Italy on 9-12 November, 2003, attracted almost 400 participants. The Scientific Committee chaired by R Giavazzi (Mario Negri Institute, Bergamo) and the board of the Italian Cancer Society produced a packed and varied program. Plenary sessions with keynote speakers (24 lectures) were combined with oral proffered papers (20 selected presentations), providing a platform from laboratory science to clinical interventions. Two hundred and sixty-one abstracts were submitted to the conference and presented in poster and poster discussion sessions, providing a stimulating ground for discussion and a network of interactive collaboration among young investigators. The venue of Bergamo offered exceptional hospitality with social events in the beautiful old town and at the Modern Art Museum. We hope that the following report gives an idea of the event and will encourage the reader to attend the 46th meeting of the SIC, 24-26 October, 2004 in Pisa.
- Published
- 2004
- Full Text
- View/download PDF
31. [Pancreatic echinococcosis].
- Author
-
Schiano di Visconte M, Lombardo C, and Munegato G
- Subjects
- Adult, Albendazole therapeutic use, Anthelmintics therapeutic use, Humans, Male, Pancreatic Diseases diagnosis, Pancreatic Diseases drug therapy, Echinococcosis diagnosis, Echinococcosis drug therapy, Pancreatic Diseases parasitology
- Abstract
Echinococcosis is a widespread parasitosis which is endemic in many countries of Latin America, Asia and Southern Europe. Cysts are generally to be found in the liver and lungs. If exceptionally located in other organs, the condition may pose serious problems of differential diagnosis versus neoplasms. Furthermore, if unnoticed, they may expose the patient--in case of surgery--to the risk of anaphylaxis due to leakage of cystic fluid. The pancreas is one of least frequent locations. Multiple surgical procedures are possible. Pericystectomy is often difficult and exposes patients to the risk of postoperative complications. Marsupialisation and internal drainage into the gut are the most common interventions; percutaneous drainage, too, has been described in patients at high surgical risk. The authors report the case of a patient from Morocco who emigrated to Northern Italy, where the disease is not endemic. The radiological examinations led to a suspicion of disease, later confirmed by serological tests. A cystojejunostomy with a Roux loop was carried out due to the large size of the cyst. The lack of surgical radicality forced the patient to undergo adequate medical therapy. At present the patient shows no signs of recurrence of the disease.
- Published
- 2003
32. [Acute abdomen due to a strangulated and perforated para-esophageal hernia. A case report].
- Author
-
Schiano di Visconte M, Barbaresco S, Burelli P, Da Ros D, Di Bella R, Lombardo C, Salemi S, and Bedin N
- Subjects
- Abdomen, Acute diagnosis, Aged, Female, Follow-Up Studies, Hernia, Hiatal diagnosis, Hernia, Hiatal diagnostic imaging, Hernia, Hiatal surgery, Humans, Radiography, Thoracic, Time Factors, Abdomen, Acute etiology, Hernia, Hiatal complications
- Abstract
Para-oesophageal hiatus hernia, a condition in which the fundus and part of the body of the stomach wrapped in a peritoneal sac herniate into the mediastinum, is a relatively uncommon entity. It tends to grow progressively and may become so large as to lead to symptoms of intrathoracic organ compression. In some exceptional cases, the entire stomach together with other abdominal viscera might herniate through the hiatus into the thorax. Paraesophageal hiatus hernias are characterised clinically by vague symptomatology, absent gastro-oesophageal reflux, and possible onset of gastric volvulus, generally without consequent incarceration of the portion of the herniated organ. Such an event is uncommon but dangerous and life-threatening. These cases often require resection of the incarcerated viscera, followed by hiatoplasty and Nissen fundoplication. The authors report on the case of a patient presenting with acute abdomen as a result of incarcerated and perforated para-oesophageal hiatus hernia.
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.